Skip to content
policyVerified

WHO lists Sinopharm’s COVID-19 vaccine for emergency use

On 7 May 2021 the World Health Organization listed Sinopharm’s BBIBP-CorV COVID-19 vaccine for emergency use. The 31 December 2020 NMPA approval is a neighbouring earlier Chinese instrument. In the causal graph this event strengthens Vaccine Accessibility, a driver that strengthens First-dose measles vaccination coverage (global, MCV1) — an improving welfare path.

Sources: [1][2]

Read the full account

On 7 May 2021 the World Health Organization listed Sinopharm’s BBIBP-CorV COVID-19 vaccine for emergency use. Xi did not sit as the SAGE panel.

Context

NMPA had authorised in December 2020. WHO is the author of the listing. China is the manufacturing state. The listing enabled COVAX procurement.

The 31 December 2020 NMPA approval is a neighbouring earlier Chinese instrument.

The General Secretary of the Chinese Communist Party, concurrently President of the People’s Republic of China and Chairman of the Central Military Commission, can set the Politburo agenda, nominate the State Council leadership, and command the armed forces. He does not write UN General Assembly resolutions, OHCHR assessments, WHO emergency-use listings, or Hong Kong ordinances by himself.

Why it matters

The path is vaccine accessibility: a completed WHO listing is a dated global-procurement ticket for a Chinese-made vaccine.

Who was responsible

Contribution type and responsibility level for each recorded actor — not sole-author shorthand.

  • Xi Jinping

    Person

    Direct responsibility

    responsibility level 0.4 · verified

    Complex: WHO listed the vaccine. China manufactured it under an Xi-era state group. He did not sit as the SAGE panel.

What changed

Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.

Evidence

The sources behind this fact and its verification state.

Verified2 sources on file
  1. 1.Reuters — WHO gives emergency-use approval to China’s Sinopharm COVID vaccineReuters · High credibility · verified
  2. 2.WHO — lists additional COVID-19 vaccine for emergency use, 7 May 2021World Health Organization · High credibility · verified
What the sources establish

World Health Organization carries the official instrument or communique. Reuters records the same dated act independently.

Established: a 7 May 2021 WHO emergency-use listing of Sinopharm’s BBIBP-CorV.

Not established: a unique later African coverage rate from the listing hour, or that Xi sat on SAGE.

China manufactured it under an Xi-era state group. He did not sit as the SAGE panel.. A later repeal, court stay, or successor order would be a different Fact with a different date. That pair identifies WHO lists Sinopharm’s COVID-19 vaccine for emergency use, not a later speech about WHO lists Sinopharm’s COVID-19 vaccine for emergency use.

Co-authors and later implementers named in Context remain on the file. If a later repeal, stay, or successor decree exists, it needs its own date and its own row. The contribution described on this Person row is limited to Complex: WHO listed the vaccine. He did not sit as the SAGE panel. That limit is the alternative to treating office-holding as authorship of every later series. The National People’s Congress, the State Council, provincial governments, the People’s Liberation Army, Hong Kong’s executive, and foreign counterparties share specific files. Allegation is not a completed judgment. An OHCHR assessment is not a criminal conviction. A white paper is not a census. A UN pledge is not a delivered emissions path.

Causal path

How this event connects to drivers and indicators in the graph.

  1. ActorXi Jinping
  2. contributed toFactWHO lists Sinopharm’s COVID-19 vaccine for emergency use
  3. strengthensDrivers (2)Vaccine Accessibility
  4. strengthensIndicatorFirst-dose measles vaccination coverage (global, MCV1)

Cite this page

Factrail. (2026). WHO lists Sinopharm’s COVID-19 vaccine for emergency use. Factrail. https://factrail.ai/facts/cn-who-eul-sinopharm-2021

https://factrail.ai/facts/cn-who-eul-sinopharm-2021

Accessed 15 October 2026.

By the Factrail desk · Method: how we source and score · Last reviewed

Dispute this factNamed here, or represent someone who is? Request a right of reply.